Singapore markets closed

Satellos Bioscience Inc. (0ITA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.28400.0000 (0.00%)
As of 08:00AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-8,778
-15,889
-11,322
-15,506
-1,579
Depreciation & amortisation
433.112
7
337
165.685
0.422
Stock-based compensation
2,115
2,169
1,440
971.532
88.607
Change in working capital
385.383
369
991
-485.639
-182.924
Accounts receivable
138.818
-
1.783
40.126
-29.409
Other working capital
-5,791
-14,519
-5,786
-5,041
-1,660
Other non-cash items
-
-
-140
9,840
5.47
Net cash provided by operating activities
-5,780
-14,501
-5,783
-5,034
-1,660
Cash flows from investing activities
Investments in property, plant and equipment
-
-18
-3
-7.246
-
Purchases of investments
-19,618
-17,520
0
-
-
Other investing activities
-
-
-
1,745
-
Net cash used for investing activities
-12.027
-17,538
-3
1,738
0
Cash flows from financing activities
Debt repayment
-
-2,528
0
-
-
Common stock issued
2,465
32,463
2,775
7,079
890.541
Dividends paid
-
0
0
-
-
Other financing activities
-
603
-
-
-
Net cash used provided by (used for) financing activities
2,650
51,033
2,775
7,451
1,978
Net change in cash
-3,142
20,143
-2,947
4,154
318.401
Cash at beginning of period
6,273
1,924
4,871
717.53
399.129
Cash at end of period
3,131
22,067
1,924
4,871
717.53
Free cash flow
Operating cash flow
-5,780
-14,501
-5,783
-5,034
-1,660
Capital expenditure
-
-18
-3
-7.246
-
Free cash flow
-5,791
-14,519
-5,786
-5,041
-1,660